If 5-Amino-1MQ raises the substrate and methylene blue raises the flow, then stacking them is the most aggressive engineered NAD+ intervention you can run without injecting NAD+ directly. This is not a beginner stack. It is a metabolic deep-cycle for users who have already exhausted the NMN-and-NR shelf and want something that actually moves a panel.
I have run this stack for two distinct twelve-week blocks under bloodwork supervision. The results were larger than either compound alone. Here is why the mechanism converges, exactly how I structured the protocol, and what the bloodwork looked like.
Quick Summary
- 5-Amino-1MQ blocks NNMT and preserves the nicotinamide pool.
- Methylene blue acts as an alternative electron acceptor in mitochondrial Complex I/III bypass.
- Stacked: substrate is preserved AND mitochondrial throughput improves.
- Dosing: 100 mg 5-Amino-1MQ daily + 5–10 mg pharmaceutical-grade methylene blue daily.
- Do not combine with SSRIs, MAOIs, or high-dose tryptophan supplements.
Two Levers, One Pathway
NAD+ collapses with age. The collapse has multiple drivers: increased CD38 activity siphoning NAD+ for cyclic ADP-ribose signaling, NNMT overexpression methylating nicotinamide into waste, and reduced mitochondrial electron-transport efficiency that lowers NAD+ turnover. Each driver invites a different countermeasure.
5-Amino-1MQ closes the NNMT drain. The nicotinamide that would have been methylated stays available for salvage into NAD+. The methyl pool — already a limiting factor in users on creatine and TMG — is spared.
Methylene blue, at low dose, accepts electrons from NADH and bypasses partial blockades in Complex I and Complex III. This keeps the NAD+/NADH ratio favorable even when mitochondrial chain efficiency is impaired. It is a redox shuttle, used in clinical medicine as an antidote to methemoglobinemia and increasingly in research as a mitochondrial-protective agent [1].
The stacking logic is precise: one compound increases the NAD+ substrate pool, the other compound increases the rate at which NADH is regenerated to NAD+. Both factors raise steady-state NAD+ concentration through different leverage points.
Tony Huge laws of biochemistry physics: Substrate Plus Throughput
One of the Tony huge laws of biochemistry Physics is that the fastest path to a metabolic outcome is to raise both the substrate and the throughput simultaneously. Raising one without the other produces a flatter response curve and a faster plateau. The 5-Amino-1MQ + methylene blue stack respects this Law by simultaneously protecting nicotinamide (substrate) and accelerating NADH oxidation (throughput).
The Methylene Blue Conversation Most Biohackers Get Wrong
Methylene blue is a dose-biphasic compound. At low dose (under 2 mg/kg), it acts as a redox shuttle, supports mitochondrial function, and has neuroprotective effects. At higher dose, it inverts and becomes a pro-oxidant, can cause hemolysis in G6PD-deficient patients, and competes with monoamine oxidase metabolism. The biohacker dose is in the 1–10 mg range — well within the protective window for an adult.
Quality matters more than for almost any other supplement. Methylene blue used in industry is contaminated with heavy metals. Only pharmaceutical-grade USP methylene blue should be ingested. The cost difference between industrial and pharmaceutical is small enough that the choice is obvious.
The serotonin syndrome warning is real. MAO-A inhibition by methylene blue at 1 mg/kg and above can precipitate serotonin syndrome in users on SSRIs, MAOIs, or high-dose tryptophan. At 5–10 mg total dose this is not a concern for most users but the rule stands: if you are on antidepressants, methylene blue is contraindicated until cleared by your prescriber.
The Natural Plus Protocol — Stacked NAD+ Deep Cycle
Phase 1 — Loading (weeks 1–4):
- 5-Amino-1MQ 100 mg once daily, morning, empty stomach.
- Methylene blue 5 mg once daily, morning, with breakfast. Pharmaceutical-grade USP only.
- Adjuncts: TMG 500 mg, NMN 500 mg, niacinamide 250 mg, vitamin B-complex.
Phase 2 — Optimization (weeks 5–12):
- 5-Amino-1MQ 100 mg once daily.
- Methylene blue 10 mg split into two 5 mg doses, morning and early afternoon.
- Adjuncts: continue.
Phase 3 — Washout and Re-Test (weeks 13–16):
- Stop both compounds.
- Continue NMN and TMG.
- Re-test bloodwork at week 16 to capture sustained effects.
Bloodwork: Baseline before Phase 1, end of Phase 2 (week 12), and end of Phase 3 (week 16). Track: NAD+ panel if available, fasting insulin, HOMA-IR, A1c, ALT, AST, GGT, CBC, comprehensive metabolic panel, vitamin B12 and folate, methylmalonic acid, hsCRP, lipid panel.
Stacking With The Wider Shelf
| Partner | Why | Notes |
|---|---|---|
| NMN 500 mg | Direct NAD+ precursor; both compounds protect/use the increased supply | Daily, morning |
| TMG 500 mg | Methyl pool defense in case 5-Amino-1MQ’s nicotinamide-sparing shifts methyl demand | Daily |
| Niacinamide 250 mg | Direct substrate feed | Twice daily |
| MOTS-c 10 mg 2×/week | Mitochondrial signaling adjuvant | Subcutaneous |
| CoQ10 200 mg | Electron transport substrate; supports methylene blue’s redox shuttle | With fat-containing meal |
| Magnesium glycinate 400 mg | Cofactor for ATP synthase | Evening for sleep architecture |
| Vitamin B complex | NAD+ pathway cofactors | Daily with breakfast |
Target Audience
This stack is for: experienced biohackers who have already cycled NMN/NR and want a step up, post-40 users with measurable insulin resistance, longevity stackers running broader regenerative protocols, cognitive optimization users (methylene blue has independent nootropic properties), and post-illness recovery users defending mitochondrial output. It is not for: SSRI/MAOI users, G6PD deficient users, pregnancy, anyone without baseline bloodwork.
Timeline Of Effects
| Window | Expected Change |
|---|---|
| Days 1–7 | Morning energy lift; blue/green urine and tongue from methylene blue (expected) |
| Weeks 2–4 | Improved exercise recovery; subjective cognitive clarity |
| Weeks 5–8 | HOMA-IR begins shifting; waist measurement drops if visceral fat is present |
| Weeks 9–12 | Bloodwork shifts crystallize; A1c improvement visible |
| Weeks 13–16 | Sustained-effect window; subsequent cycles can be shorter |
Interesting Perspectives
The hypocrisy angle: methylene blue was the first antimalarial. It was the original synthetic drug. It has been in clinical use for over 130 years. The same medical establishment that prescribes it intravenously for methemoglobinemia treats biohackers using 5 mg orally as reckless. The dose difference is two orders of magnitude in the safer direction. The skepticism is performative.
The cross-domain connection: methylene blue’s mitochondrial mechanism is the same as the recently popular SLU-PP-332 ERR agonists, photobiomodulation red-light therapy, and CoQ10 — they all converge on supporting mitochondrial electron transport. Methylene blue is the cheap, oral, century-old member of that family. The newer entries have not invalidated the original.
Frequently Asked Questions
Is methylene blue safe with caffeine? Yes. Caffeine does not interact with the methylene-blue redox shuttle.
Will the blue urine bother me? It is harmless. Some users find it amusing. If it bothers you, the dose is too high or the formulation is wrong.
Can I take methylene blue with NMN? Yes — they target adjacent but non-overlapping nodes.
Do I need to cycle? Yes. Twelve weeks on, four weeks off is the sensible cadence for this engineered stack.
References
- Tucker D, et al. “From mitochondrial function to neuroprotection — an emerging role for methylene blue.” Mol Neurobiol. 2018. PMID: 28432541
- Neelakantan H, et al. “Selective and membrane-permeable small molecule inhibitors of NNMT.” Biochem Pharmacol. 2018. PMID: 29555331
- Atamna H, et al. “Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways.” FASEB J. 2008. PMID: 17872807
- Yano CL, Kanno T. “Sources of intracellular reactive oxygen species and the regulation of NAD+ metabolism.” Annu Rev Biochem. 2020.
- Rojas JC, Bruchey AK, Gonzalez-Lima F. “Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.” Prog Neurobiol. 2012. PMID: 22484748
Where To Go Next
Start at the Enhanced Athlete Protocol hub for the broader regenerative system. The supplements pillar covers cofactor stacking. The peptide pillar contextualizes 5-Amino-1MQ within the broader peptide shelf. The recovery pillar covers sleep and parasympathetic context. The bloodwork guide tells you exactly what to baseline.